Interactions on record — worth a quick check against your medications. Check your meds →
Dietary supplement

Pediatric D-VITE Drops Delicious Bubble Gum Flavor Ingredients & Drug Interactions

by Akron Pharma

Liquid Category: Vitamin
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Pediatric D-VITE Drops Delicious Bubble Gum Flavor is a dietary supplement by Akron Pharma with 1 active ingredient. Its ingredients are commonly taken for bone health and osteoporosis, correcting vitamin d deficiency, immune system support.Based on those ingredients, 715 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Vitamin D. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Pediatric D-VITE Drops Delicious Bubble Gum Flavor by Akron Pharma

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 1 of its 1 active ingredient.
  • No proprietary blends here — you can verify the dose of every single component.

Pediatric D-VITE Drops contains one active ingredient: vitamin D. It's formulated as a liquid with bubble gum flavoring to make it easier for children to take.

The product also contains several inactive ingredients — sorbitol, propylene glycol, glycerol, and other agents that give the drops their texture, taste, and shelf life.

Does it work?

Strong evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Strong

Clinical evidence supports at least one of this product's ingredients for its stated purpose.

Why this rating?
  • The label markets this product for: Vitamin D supplementation for breastfed infants.
  • We looked for evidence on: Infant development, Child growth, Rickets, Osteomalacia, Fetal and premature infant mortality, Prematurity — and 3 related terms.
  • The strongest evidence on file: Vitamin D is rated "Effective" for Osteomalacia (Natural Medicines).
  • Also on file: Vitamin D is rated "Effective" for Rickets, Vitamin D deficiency.
  • Also on file: Vitamin D is rated "Insufficient Reliable Evidence To Rate" for Bronchopulmonary dysplasia, Fetal and premature infant mortality, Prematurity, Infant development.

Vitamin D in this product is effective for treating rickets, renal bone disease (renal osteodystrophy), softened bones from vitamin D deficiency (osteomalacia), and familial hypophosphatemia — all serious conditions where the body cannot maintain proper bone health or calcium balance. It's also effective for hypoparathyroidism.

Your child's doctor will determine whether vitamin D supplementation is right for your child's specific situation.

The evidence, ingredient by ingredient Vitamin D

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Vitamin D is generally well tolerated at recommended doses, but very high doses over time can cause toxicity — symptoms include high blood calcium (hypercalcemia), weak bones, and in children, slowed growth or vision problems. The product is likely safe during pregnancy and breastfeeding at recommended amounts, though one entry notes a possibly unsafe rating for pregnancy — talk with your child's doctor about the right dose for your situation.

Serious side effects are rare when used as directed, but always follow dosing instructions carefully.

Side effects, ingredient by ingredient Vitamin D

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Vitamin D.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: heart-rhythm medications.
  • For scale: 716 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before giving this product to your child, check with their doctor or pharmacist if they take water pills (thiazide diuretics), heart rhythm medications like verapamil or diltiazem, digoxin, atorvastatin (Lipitor), or vitamin D analogs like calcipotriene. These are moderate-severity concerns tied to high doses of vitamin D — the product's actual pediatric dose will determine real risk.

Also mention any aluminum-containing products or other medications metabolized by the liver enzyme CYP3A4.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with clinical evidence supporting its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

This product is designed for children who need vitamin D for specific bone and mineral disorders — rickets, renal bone disease, low vitamin D levels, and related conditions. If your child takes heart medications, cholesterol drugs, or water pills, check with your child's doctor or pharmacist before starting these drops, as vitamin D can interact with them.

Make sure your child's doctor knows about any other medications or supplements before beginning treatment.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Nov 19, 2021.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Pediatric D-VITE Drops Delicious Bubble Gum Flavor, straight from the product label.

Brand Akron Pharma
Barcode (UPC) 371399740151
Net contents 1.66 Fluid Ounce(s); 50 Milliliter(s)
Market status On market
Date entered into DSLD Nov 19, 2021
DSLD ID 263352
Product type Vitamin
Supplement form Liquid
Dietary claims / uses Nutrient, All Other, Structure/Function
Intended target group(s) Kosher, Infants/Baby (0 - 1 Year), Halal, Gluten Free, Sugar Free, Children more than 1 but less than 4
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Pediatric D-VITE Drops Delicious Bubble Gum Flavor by Akron Pharma, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Infants
Minimum serving Sizes:
1 mL
Maximum serving Sizes:
1 mL
Servings per container
50
UPC/BARCODE
371399740151
IngredientAmount% DV
Vitamin D10 mcg100%, 100%

Other ingredients: Vitamin D3, Sorbitol, Propylene Glycol, Glycerol, Polysorbate 80, Sodium Benzoate, Disodium Edetate, Citric Acid, Artificial flavor, Sodium Saccharin, Caramel, Liquid, Butylated Hydroxyanisole, Butylated Hydroxytoluene, Water, Purified

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

71399-7401-5 Compare to vitamins in D.VI.SOL Easy-to use dropper

The American Academy of Pediatrics (AAP) recommends using a vitamin D supplement for exclusively and partially breastfed babies because of the low average levels of vitamin D in breast milk.

Save this carton for full labeling information.

See top flap of the carton for lot no# and expiration date. FSSAI Lic. No.: 10017042003338 Questions or comments? Call us toll free: 1-877-225-6999

FDA Statement of Identity

Liquid Vitamin D Supplement

Dietary Supplement

Formulation

Essential for all breastfed infants

No artificial colors Gluten free Alcohol free

D-VITE Drops provides essential vitamin that helps your baby's body absorb calcium for strong bones and teeth. D-VITE Drops complements your breast milk to help provide optimal nutrition for your baby.

D-VITE Drops is sugar-free, gluten-free and lactose-free.

Formula

(Vitamin) D

One daily dose of D-VITE Drops has vitamin D with bubble gum flavored.

Halal

WRG Certification WRG Kosher Registered

Suggested/Recommended/Usage/Directions

Usage: As a dietary supplement, take 1 ml daily after food or as directed by your physician.

Shake well before use.

Use only with enclosed dropper Directions for use: Administer this supplement using only the device provided. Shake bottle well and fill dropper to 1.0 ml. line. Dosage not to exceed 1.0ml. per day unless doctor recommends another dosage. Dispense directly into mouth or mixed with formula, fruit juice, cereal, or other foods. Rinse and retain device for further dosing of this product.

Storage

Storage: Store at 15 degrees-30 degrees C (59 degrees-86 degrees F). Protect from freezing. After opening, store away from direct light. Refrigerator is not required.

Precautions

Warning: As with medicine, keep out of reach of children.

Tamper evident: Do not use if safety seal under cap is broken or missing.

If you have any questions concerning your child's supplement needs, please consult your child's physician.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Seals/Symbols

Halal WRG Certification WRG Kosher Registered

Brand IP Statement(s)

Akron Pharma Inc is not affiliated with the owner of the trademark D.VI.SOL

See for yourself

Pediatric D-VITE Drops Delicious Bubble Gum Flavor by Akron Pharma label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Pediatric D-VITE Drops Delicious Bubble Gum Flavor by Akron Pharma

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size1 mL Dosage formLiquid Servings per container50 Amounts shown are per serving.

Vitamin D

Interacts with
715 drugs
10 mcg per serving Form: Cholecalciferol

Vitamin D is a fat-soluble vitamin that helps your body absorb calcium and is important for healthy bones, muscles, and immune function. Many people,...

Vitamin D monograph & interactions

Other (inactive) ingredients: Vitamin D3, Sorbitol, Propylene Glycol, Glycerol, Polysorbate 80, Sodium Benzoate, Disodium Edetate, Citric Acid, Artificial flavor, Sodium Saccharin, Caramel, Liquid, Butylated Hydroxyanisole, Butylated Hydroxytoluene, Water, Purified. These complete the product’s ingredient list but are not active constituents.

Interaction report

Pediatric D-VITE Drops Delicious Bubble Gum Flavor by Akron Pharma Drug Interactions

Want to check YOUR meds against Pediatric D-VITE Drops Delicious Bubble Gum Flavor?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
715Drugs
80 Moderate 635 Minor

Ingredients driving the most interactions

Vitamin D 715

Each ingredient & the kinds of drugs it affects

For each ingredient in Pediatric D-VITE Drops Delicious Bubble Gum Flavor with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

Vitamin D8 drug types · 715 drugs

Aluminum

Vitamin D might increase aluminum absorption and toxicity, but this has only been reported in people with renal failure.
The protein that transports calcium across the intestinal wall can also bind and transport aluminum. This protein is stimulated by vitamin D, which may therefore increase aluminum absorption. This mechanism may contribute to increased aluminum levels and toxicity in people with renal failure, when they take vitamin D and aluminum-containing phosphate binders chronically.

Likelihood Probable Evidence B
Atorvastatin (Lipitor)

Vitamin D might reduce absorption of atorvastatin.
A small, low-quality clinical study shows that taking vitamin D reduces levels of atorvastatin and its active metabolites by up to 55%. However, while atorvastatin levels decreased, total cholesterol, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol levels did not substantially change. Atorvastatin is metabolized in the gut by CYP3A4 enzymes, and researchers theorized that vitamin D might induce CYP3A4, causing reduced levels of atorvastatin. However, this proposed mechanism was not specifically studied.

Likelihood Probable Evidence B
Calcipotriene (Dovonex)

Taking calcipotriene with vitamin D increases the risk for hypercalcemia.
Calcipotriene is a vitamin D analog used topically for psoriasis. It can be absorbed in sufficient amounts to cause systemic effects, including hypercalcemia. Theoretically, combining calcipotriene with vitamin D supplements might increase the risk of hypercalcemia.

Likelihood Probable Evidence D
Digoxin (Lanoxin)

Theoretically, hypercalcemia induced by high-dose vitamin D can increase the risk of arrhythmia from digoxin.
High doses of vitamin D can cause hypercalcemia. Hypercalcemia increases the risk of fatal cardiac arrhythmias with digoxin. Avoid vitamin D doses above the tolerable upper intake level (4000 IU daily for adults) and monitor serum calcium levels in people taking vitamin D and digoxin concurrently.

Likelihood Possible Evidence D
Diltiazem (Cardizem, Others)

Theoretically, hypercalcemia induced by high-dose vitamin D can reduce the therapeutic effects of diltiazem for arrhythmia.
High doses of vitamin D can cause hypercalcemia. Hypercalcemia can reduce the effectiveness of verapamil in atrial fibrillation. Theoretically this could also occur with diltiazem. Avoid vitamin D doses above the tolerable upper intake level (4000 IU daily for adults) and monitor serum calcium levels in people taking vitamin D and diltiazem concurrently.

Likelihood Probable Evidence B
Thiazide Diuretics

Theoretically, taking thiazide diuretics and high-dose vitamin D can increase the risk of hypercalcemia.
Thiazide diuretics decrease urinary calcium excretion, which could lead to hypercalcemia if vitamin D supplements are taken concurrently. This has been reported in people being treated with vitamin D for hypoparathyroidism, and also in elderly people with normal parathyroid function who were taking a thiazide, vitamin D, and calcium-containing antacids daily.

Likelihood Probable Evidence D
Verapamil (Calan, Others)

Hypercalcemia induced by high-dose vitamin D can reduce the therapeutic effects of verapamil for arrhythmia.
Hypercalcemia due to high doses of vitamin D can reduce the effectiveness of verapamil in atrial fibrillation. Avoid vitamin D doses above the tolerable upper intake level (4000 IU daily for adults) and monitor serum calcium levels in people taking vitamin D and verapamil concurrently.

Likelihood Probable Evidence B
Cytochrome P450 3A4 (Cyp3A4) Substrates

Vitamin D might induce CYP3A4 enzymes and reduce the bioavailability of CYP3A4 substrates.
There is some concern that vitamin D might induce CYP3A4. In vitro research suggests that vitamin D induces CYP3A4 transcription. Additionally, observational research has found that increased UV light exposure and serum vitamin D levels are associated with decreased serum levels of CYP3A4 substrates such as tacrolimus and sirolimus, while no association between UV light exposure or vitamin D levels and levels of mycophenolic acid, a non-CYP3A4 substrate, was found. A small, low-quality clinical study shows that taking vitamin D reduces levels of the CYP3A4 substrate atorvastatin and its active metabolites by up to 55%; however, the clinical effects of atorvastatin were not reduced. While researchers theorized that vitamin D might induce CYP3A4, this proposed mechanism was not specifically studied.

Likelihood Possible Evidence D
The maker

Brand information

Manufacturer and brand details for Pediatric D-VITE Drops Delicious Bubble Gum Flavor, from the product label.

Akron Pharma

See all Akron Pharma products
Name
Akron Pharma
Street Address
373 Route US 46W, Suite 117
City
Fairfield
State
NJ
ZipCode
07004
Phone Number
1-877-225-6999
Pharmacist Counseling Corner

Pediatric D-VITE Drops Delicious Bubble Gum Flavor by Akron Pharma: Common Questions

Does Pediatric D-VITE Drops Delicious Bubble Gum Flavor by Akron Pharma interact with any medications?
Yes. Based on its ingredients, Pediatric D-VITE Drops Delicious Bubble Gum Flavor has a known interaction with 715 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Pediatric D-VITE Drops Delicious Bubble Gum Flavor contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Is vitamin D in this product proven to work?
Yes — vitamin D is effective for treating rickets, weak bones from vitamin D deficiency (osteomalacia), renal bone disease, and hypoparathyroidism. Your child's doctor will decide if this product is right for your child's condition.
Can I give this to my child if I'm pregnant or breastfeeding?
Vitamin D is likely safe during breastfeeding at recommended doses. During pregnancy, the data shows it's likely safe, but one source flags it as possibly unsafe — talk with your doctor about what's right for you and whether you should take it or avoid higher amounts.
What are the side effects?
At recommended doses, vitamin D is well tolerated. Serious side effects are rare, but taking excessive amounts over time can cause toxicity — high blood calcium, weak bones, slowed growth in children, or eye problems. Always follow the dose your child's doctor prescribes.
What does vitamin D actually do in the body?
Vitamin D helps your body absorb calcium and maintain healthy bones and minerals. In children with rickets or renal bone disease, it restores the body's ability to keep calcium and phosphorus in balance so bones can grow and strengthen properly.
Is this safe for long-term use?
Vitamin D is generally safe at recommended doses over time, but very high doses can build up and cause toxicity. Your child's doctor will monitor how much vitamin D your child needs and adjust the dose as your child grows and their condition changes.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Pediatric D-VITE Drops Delicious Bubble Gum Flavor is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Pediatric D-VITE Drops Delicious Bubble Gum Flavor label
Go deeper

The Full Monographs Behind Pediatric D-VITE Drops Delicious Bubble Gum Flavor’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Sources

Sources & How We Checked

Pediatric D-VITE Drops Delicious Bubble Gum Flavor's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 26 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Vitamin D 26 references
  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Tatro DS, ed. Drug Interactions Facts. Facts and Comparisons Inc., St. Louis, MO. 1999.
  3. Koutkia P, Chen TC, Holick MF. Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 2001;345:66-7. PubMed
  4. Bar-Or D, Yoel G. Calcium and calciferol antagonize effect of verapamil in atrial fibrillation. Br Med J 1981;282:1585-6.
  5. Demontis R, Leflon A, Fournier A, et al. 1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialyzed patients taking AI(OH)3. Clin Nephrol 1986;26:146-9.
  6. Crowe M, Wollner L, Griffiths RA. Hypercalcemia following vitamin D and thiazide therapy in the elderly. Practitioner 1984;228:312-3.
  7. Parfitt AM. Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism. Ann Intern Med 1972;77:557-63. PubMed
  8. Thiazide diuretics and the risk of osteoporosis. Pharmacist's Letter/Prescriber's Letter 2003;19(11):191105.
  9. Moon J. The role of vitamin D in toxic metal absorption. J Am Coll Nutr 1994;13:559-64.
  10. Demontis R, Reissi D, Noel C, et al. Indirect clinical evidence that 1alphaOH vitamin D<SUB>3</SUB> increases the intestinal absorption of aluminum. Clin Nephrol 1989;31:123-7.
  11. Adler AJ, Berlyne GM. Duodenal aluminum absorption in the rat: effect of vitamin D. Am J Physiol 1985;249:G209-13. PubMed
  12. Schwartz JB. Effects of vitamin D supplementation in atorvastatin-treated patients: A new drug interaction with an unexpected consequence. Clin Pharmacol Ther 2009;85:198-203. PubMed
  13. Dietary reference intakes for calcium and vitamin D. Institute of Medicine, November 30, 2010. Available at: http://www.iom.edu/~/media/Files/Report%20Files/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Vitamin%20D%20and%20Calcium%202010%20Repo
  14. Cox KA, Dunn MA. Aluminum toxicity alters the regulation of calbindin-D28k protein and mRNA expression in chick intestine. J Nutr 2001;131:2007-13. PubMed
  15. Escribano, J., Balaguer, A., Pagone, F., Feliu, A., and Roque, I. Figuls. Pharmacological interventions for preventing complications in idiopathic hypercalciuria. Cochrane.Database.Syst.Rev. 2009;(1):CD004754. PubMed
  16. Carlton, S., Clopton, D., and Cappuzzo, K. A. Vitamin D deficiency: appropriate replenishment therapies and the effects of vitamin D toxicity. Consult Pharm 2010;25(3):171-177. PubMed
  17. Wang, H., Xia, N., Yang, Y., and Peng, D. Q. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 2012;11:42. PubMed
  18. Turner AN, Carr Reese P, Fields KS, Anderson J, Ervin M, Davis JA, Fichorova RN, Roberts MW, Klebanoff MA, Jackson RD. A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis. Am J Obstet G PubMed
  19. Weiner M, Epstein FH. Signs and symptoms of electrolyte disorders. Yale J Biol Med. 1970;43(2):76-109.
  20. Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, Baggerly K, McDonnell SL. Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial. JAMA. 2017 Mar 28;317(12):1234-1243. PubMed
  21. Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E. Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials. BMJ. 2017;359:j5237. PubMed
  22. Murai IH, Fernandes AL, Sales LP, et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial. JAMA. 2021.
  23. Wang Z, Schuetz EG, Xu Y, Thummel KE. Interplay between vitamin D and the drug metabolizing enzyme CYP3A4. J Steroid Biochem Mol Biol 2013;136:54-8. PubMed
  24. Doyle D, Browne U, Brickley A, Murphy D. Vitamin D-induced hypercalcaemia and acute kidney injury in sarcoidosis. BMJ Case Rep 2023;16(1):e250580. PubMed
  25. Williamson A, Martineau AR, Sheikh A, Jolliffe D, Griffiths CJ. Vitamin D for the management of asthma. Cochrane Database Syst Rev 2023;2(2):CD011511. PubMed
  26. Kinesya E, Santoso D, Gde Arya N, et al. Vitamin D as adjuvant therapy for diabetic foot ulcers: Systematic review and meta-analysis approach. Clin Nutr ESPEN 2023;54:137-143. PubMed

See these in context on the Vitamin D monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring